BMPR2 and pulmonary arterial hypertension: A previous study using MON-Bmpr2 knockout mice induced by LysM-Cre found that the VEGF receptor inhibitor Sugen 5416, when combined with hypoxia was required to induce more severe pulmonary hypertension than in control mice [6, 9].